登革热疫苗的全球市场:各终端用户(医院，政府机关，NGO)，各地区(中南美，中东、非洲，其他地区)-规模，占有率，展望，机会分析(2022年～2028年)

Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), and By Region (Latin America, Middle East, Africa, and Rest of World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月09日 | 出版商:

Coherent Market Insights | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

登革热的盛行率增加，预计在预测期间内促进全球登革热疫苗市场成长。

本报告提供全球登革热疫苗市场的相关调查，市场展望，市场动态，市场分析，竞争情形等全面性资讯。

Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual's tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global Dengue Vaccine and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Dengue Vaccine based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Dengue Vaccine Market, By End User:
- Hospitals
- Government Institutes
- NGOs
Dengue Vaccine Market, By Region:
- Latin America
  - By End User
  - Hospitals
  - Government Institutes
  - NGOs
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Asia Pacific
  - By End User
  - Hospitals
  - Government Institutes
  - NGOs
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By End User
  - Hospitals
  - Government Institutes
  - NGOs
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By End User
  - Hospitals
  - Government Institutes
  - NGOs
  - By Country:
  - South Africa
  - Central Africa
  - North Africa
- Rest of World
  - By End User
  - Hospitals
  - Government Institutes
  - NGOs
Company Profiles
- Sanofi *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline
- Merck & Co.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Product Approval
Regulatory Scenario

4. Global Dengue Vaccine Market, By End User 2017 - 2028, (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospitals
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Government Institutes
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
NGOs
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Dengue Vaccine Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
Market Share Analysis, By Region, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2028
Latin America
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Asia Pacific
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
South Africa
Central Africa
North Africa
Rest of World
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, 2017 - 2028, (US$ Mn)

6. Competitive Landscape

Company Profiles
Sanofi
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Takeda Pharmaceutical Company Limited
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

7. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

登革热疫苗的全球市场:各终端用户(医院，政府机关，NGO)，各地区(中南美，中东、非洲，其他地区)-规模，占有率，展望，机会分析(2022年～2028年)

Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), and By Region (Latin America, Middle East, Africa, and Rest of World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028